Community and provider perceptions and experiences of cervical cancer screening in Rural Bolivia: a qualitative study.


Journal

BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690

Informations de publication

Date de publication:
05 07 2023
Historique:
received: 04 03 2023
accepted: 21 06 2023
medline: 7 7 2023
pubmed: 6 7 2023
entrez: 5 7 2023
Statut: epublish

Résumé

Despite efforts to increase cervical cancer screening access in rural Bolivia, uptake remains low. Bolivia has one of the highest cervical cancer mortality rates in the Americas. As it redoubles efforts to deliver Universal Health Care, the Bolivian government needs information on the factors constraining cervical cancer screening access and utilization, especially in rural areas. Our qualitative study explored cervical cancer screening barriers and described community and provider perceptions and experiences of care. Bolivian and US researchers analyzed data collected from eight focus groups with male and female community members (n = 80) and interviews with healthcare providers (n = 6) in four purposively selected rural communities in Hernando Siles, Bolivia. Deductive and inductive codes were used to thematically analyze data using MaxQDA software. Four themes emerged from the data: lack of knowledge/misconceptions, health system inadequacy, lack of confidence in providers, and opportunities for improvement. Both men and women displayed misconceptions about the causes of cervical cancer, its consequences, the recommended screening frequency, and the means of accessing care. Providers noted community members' lack of knowledge and low risk-perception as utilization barriers but also highlighted poor health service quality and inconsistent health education as factors. Poor healthcare quality was a significant barrier; this included poor patient-provider communication, lack of transportation to screening facilities, and severe delays in receiving test results. Providers also noted problems with provider training and physical space for screening. Community members reported low confidence in nurses to perform screening, preferring doctors and specialists. They also expressed discomfort in having male healthcare providers conduct screening. Suggestions for improvements included more intensive cervical cancer outreach to rural areas and having specialists train lower-level providers to perform screening. Our findings suggest that poor healthcare quality has affected screening uptake in addition to physical barriers to care. They indicate a need for initiatives to reduce reporting time for Pap test results, the incorporation of community-based HPV self-sampling into screening protocols, and the implementation of programs to improve community confidence in providers' ability to perform screening.

Sections du résumé

BACKGROUND
Despite efforts to increase cervical cancer screening access in rural Bolivia, uptake remains low. Bolivia has one of the highest cervical cancer mortality rates in the Americas. As it redoubles efforts to deliver Universal Health Care, the Bolivian government needs information on the factors constraining cervical cancer screening access and utilization, especially in rural areas.
METHODS
Our qualitative study explored cervical cancer screening barriers and described community and provider perceptions and experiences of care. Bolivian and US researchers analyzed data collected from eight focus groups with male and female community members (n = 80) and interviews with healthcare providers (n = 6) in four purposively selected rural communities in Hernando Siles, Bolivia. Deductive and inductive codes were used to thematically analyze data using MaxQDA software.
RESULTS
Four themes emerged from the data: lack of knowledge/misconceptions, health system inadequacy, lack of confidence in providers, and opportunities for improvement. Both men and women displayed misconceptions about the causes of cervical cancer, its consequences, the recommended screening frequency, and the means of accessing care. Providers noted community members' lack of knowledge and low risk-perception as utilization barriers but also highlighted poor health service quality and inconsistent health education as factors. Poor healthcare quality was a significant barrier; this included poor patient-provider communication, lack of transportation to screening facilities, and severe delays in receiving test results. Providers also noted problems with provider training and physical space for screening. Community members reported low confidence in nurses to perform screening, preferring doctors and specialists. They also expressed discomfort in having male healthcare providers conduct screening. Suggestions for improvements included more intensive cervical cancer outreach to rural areas and having specialists train lower-level providers to perform screening.
CONCLUSIONS
Our findings suggest that poor healthcare quality has affected screening uptake in addition to physical barriers to care. They indicate a need for initiatives to reduce reporting time for Pap test results, the incorporation of community-based HPV self-sampling into screening protocols, and the implementation of programs to improve community confidence in providers' ability to perform screening.

Identifiants

pubmed: 37407967
doi: 10.1186/s12905-023-02500-2
pii: 10.1186/s12905-023-02500-2
pmc: PMC10324272
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

359

Informations de copyright

© 2023. The Author(s).

Références

BMC Womens Health. 2021 Mar 23;21(1):122
pubmed: 33757512
BMC Health Serv Res. 2013 Jan 16;13:22
pubmed: 23320786
BMJ Open. 2017 Jul 2;7(6):e014888
pubmed: 28674138
BMJ Open. 2019 Oct 28;9(10):e029158
pubmed: 31662358
BMJ Open. 2021 Jun 17;11(6):e043637
pubmed: 34140340
Patient Prefer Adherence. 2015 Mar 24;9:501-8
pubmed: 25848229
Prev Med Rep. 2021 Dec 27;25:101684
pubmed: 35127361
BMJ Glob Health. 2021 May;6(5):
pubmed: 34011537
Glob Health Action. 2015 Jan 22;8:26282
pubmed: 25623612
BMC Infect Dis. 2020 Apr 3;20(1):259
pubmed: 32245369
Health Care Women Int. 2017 Dec;38(12):1289-1312
pubmed: 28825525
Glob Public Health. 2022 Jun;17(6):971-985
pubmed: 33573491
Transcult Psychiatry. 2020 Feb;57(1):94-107
pubmed: 31937197
Ecancermedicalscience. 2019 Jan 31;13:901
pubmed: 30915159
BMC Womens Health. 2017 Dec 22;17(1):135
pubmed: 29273032
Prev Med Rep. 2020 Oct 02;20:101212
pubmed: 33224718
Healthcare (Basel). 2022 Aug 24;10(9):
pubmed: 36141216
Int J Gynaecol Obstet. 2020 May;149(2):123-129
pubmed: 32037532
Indian J Cancer. 2018 Oct-Dec;55(4):318-326
pubmed: 30829264
Rev Panam Salud Publica. 2005 Jul;18(1):53-63
pubmed: 16105327
J Glob Oncol. 2018 Jul;4:1-10
pubmed: 30084698
World Health Forum. 1992;13(2-3):182-7
pubmed: 1418332
BMC Womens Health. 2019 Aug 9;19(1):108
pubmed: 31399092
BMJ Open. 2019 Mar 13;9(3):e026413
pubmed: 30872552
Health Policy Plan. 2016 Feb;31(1):114-28
pubmed: 25953966
BMC Public Health. 2019 Jan 17;19(1):80
pubmed: 30654774
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Asian Pac J Cancer Prev. ;18(7):1751-1763
pubmed: 28749101
Prev Med. 2018 Sep;114:149-155
pubmed: 29958860

Auteurs

Armando Basagoitia (A)

Salud Global, Urriolagoitia #354 Primer Piso Urriolagoitia 354, Sucre, Bolivia. armando.basagoitia@gmail.com.

Sahai Burrowes (S)

Touro University California Public Health Program, CEHS, 1310 Club Drive Vallejo, Vallejo, CA, 94592, USA.

Maria Teresa Solis-Soto (MT)

Universidad de O'Higgins, Libertador Bernando O'Higgins 611, Rancangua, O'Higgins, Chile.

Genevieve MacMillan (G)

Touro University California Public Health Program, CEHS, 1310 Club Drive Vallejo, Vallejo, CA, 94592, USA.

Sarah Sullivan (S)

Touro University California Public Health Program, CEHS, 1310 Club Drive Vallejo, Vallejo, CA, 94592, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH